pifithrin has been researched along with evans blue in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auld, DS; Austin, CP; Diller, DJ; Inglese, J; Jadhav, A; Johnson, RL; Simeonov, A; Southall, NT | 1 |
| Cavalieri, TA; Hock, CE; Liu, P; Xu, B | 1 |
2 other study(ies) available for pifithrin and evans blue
| Article | Year |
|---|---|
Characterization of chemical libraries for luciferase inhibitory activity.
Topics: Animals; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fireflies; Luciferases; Models, Molecular; Structure-Activity Relationship | 2008 |
Pifithrin-alpha attenuates p53-mediated apoptosis and improves cardiac function in response to myocardial ischemia/reperfusion in aged rats.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Benzothiazoles; DNA Fragmentation; Electrocardiography; Evans Blue; Heart; Myocardial Ischemia; Myocytes, Cardiac; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred F344; Reperfusion Injury; Toluene; Tumor Suppressor Protein p53 | 2006 |